Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

Bluepharma

NIF 506037169
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,195,512 144 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,195,512 144 contracts
A2 · Late Publication €1,213,592,221 709 contracts
Contract published to BASE more than 10 days after the signing date
LOW €1,213,592,221 709 contracts
A5 · Threshold Splitting €1,898,508 23 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,898,508 23 contracts
A6 · Low Competition €6,300 2 contracts
Only one bidder participated in a competitive procedure
MEDIUM €6,300 2 contracts
A9 · Abnormal Price Reduction €1,532,943,936 675 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €1,532,943,936 675 contracts
C3 · Missing Mandatory Fields €496,654 33 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €496,654 33 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

27
€90,709,203
25
€71,871,293
80
€71,109,730
13
€71,018,205
24
€70,007,303
114
€69,489,524
31
€68,307,907
9
€60,798,665
44
€60,033,117
20
€58,706,907
19
€58,045,103
26
€50,967,088
9
€49,857,071
20
€48,820,243
24
€46,923,901
27
€46,689,047
19
€45,945,728
14
€45,808,511
53
€45,732,015
33
€44,963,462
Page 1 of 3 · 59 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 3 · 144 contracts

040102212026 PAZOPANIB 400 MG COMP
PT · 13086409 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€6,000 2026-01-28
040126522025 - TADALAFIL 20 MG COMP
PT · 12402246 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€4,860 2025-12-29
ADCM 5270/25 - MEDICAMENTOS
PT · 12942828 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€141,154 2025-12-17
ADCM 5160/25 - MEDICAMENTOS
PT · 12547305 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€745 2025-12-10
MEDICAMENTOS BLUEPHARMA
PT · 11965146 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€315 2025-11-13
ADCM 4629/25 - medicamentos diversos
PT · 12128287 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€129,353 2025-11-10
VENLAFAXINA 150 MG CÁPS LP
PT · 11839645 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€178 2025-10-20
AQUISIÇÃO URGENTE MEDICAMENTOS
PT · 11837935 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€56,535 2025-10-03
Medicamentos
PT · 11680861 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A9 · Abnormal Price Reduction
€17,970 2025-08-28
Medicamentos
PT · e2ca9b2fcb6db17f411c · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€81 2025-08-28
Medicamentos
PT · 11679682 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A9 · Abnormal Price Reduction
€9,796 2025-08-25
Medicamentos
PT · 47d2ebf3ff0af4a884f6 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€81 2025-08-25
Medicamentos
PT · 11873480 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€4,281 2025-05-30
Medicamentos
PT · 11551155 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€17,508 2025-05-29
Medicamentos
PT · 11519665 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€15,124 2025-05-15
Medicamentos
PT · 11525170 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€8,966 2025-05-06
Medicamentos
PT · 11522702 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€15,930 2025-04-24
Medicamentos
PT · 11526351 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€9,212 2025-04-24
Medicamentos
PT · 11529290 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€5,736 2025-04-23
OLANzapina 5 mg Comp orodisp
PT · 11524145 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€191 2025-04-21
Medicamentos
PT · 11564225 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€12,626 2025-04-17
EC Abiraterona 20180146
PT · 11478305 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€447 2025-04-02
ADCM 1546/25 - MEDICAMENTOS DIVERSOS
PT · 11546016 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€103,690 2025-03-31
Medicamentos
PT · dd80785975864afb5f40 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€50 2025-03-25
Medicamentos
PT · fe8122b43a51fcd2e095 · Ajuste Direto Regime G...
A2 · Late Publication A1 · Repeat Direct Award
€427 2025-03-19
Brometo de ipratrópio 20 mcg/dose Sol pressu inal Recip pressu 200 dose(s)
PT · 11471091 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€330 2025-03-17
Medicamentos
PT · 11339251 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€23,426 2025-03-12
Medicamentos
PT · 11321377 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€12,474 2025-03-12
Medicamentos
PT · 9c24d96b03e7e5e6ead3 · Ajuste Direto Regime G...
A2 · Late Publication A1 · Repeat Direct Award
€32 2025-03-12
VÁRIOS MEDICAMENTOS
PT · 11278490 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€10,485 2025-03-10
Medicamentos
PT · 11322228 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€11,622 2025-03-03
Brometo de ipratrópio 20 mcg/dose Sol pressu inal Recip pressu 200 dose(s)
PT · 11344218 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€660 2025-02-24
SUNitinib
PT · 11324917 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€735 2025-02-10
Brometo de ipratrópio
PT · 11307332 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€273 2025-02-07
VÁRIOS MEDICAMENTOS
PT · 11250325 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€26,348 2025-02-07
Medicamentos
PT · 11318652 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€11,484 2025-02-05
1064125 - OLANzapina 5 mg Comp orodisp
PT · 11344146 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€191 2025-01-28
Medicamentos
PT · 11261888 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€49,746 2025-01-22
Medicamentos
PT · 11314331 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€45,395 2025-01-15
Medicamentos
PT · 11263729 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€115,905 2025-01-14
VÁRIOS MEDICAMENTOS
PT · 11183425 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€82,797 2025-01-13
MEDICAMENTOS
PT · 11130041 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€74,145 2024-12-18
MEDICAMENTOS
PT · 520791c642e63a7a71b7 · Ajuste Direto Regime G...
A2 · Late Publication A1 · Repeat Direct Award
€136 2024-12-18
MEDICAMENTOS
PT · 11129605 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€26,303 2024-12-11
MEDICAMENTOS
PT · 11129517 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€17,209 2024-12-11
MEDICAMENTOS
PT · 11091060 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A9 · Abnormal Price Reduction
€5,616 2024-12-11
MEDICAMENTOS
PT · 4e4e1bf9dfe5e6af182b · Ajuste Direto Regime G...
A2 · Late Publication A1 · Repeat Direct Award
€51 2024-12-11
MEDICAMENTOS
PT · 418658557b0003f32b71 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€52 2024-12-11
MEDICAMENTOS
PT · 11144457 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€179,172 2024-12-10
Brometo de ipratrópio 20 mcg/dose
PT · 11186626 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€330 2024-12-09
Next →
Overview
Total Value Won
€1,537,083,913
Contracts Won
1,031
Score 43815 · CRITICAL RISK
NIF
506037169
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.P. [P-8cdc]
    Administrador
    since 2009-05-25
  • C.M. [P-8c51]
    Administrador
    since 2009-05-25
  • F.J. [P-03ef]
    Presidente
    since 2009-05-25
  • I.S. [P-cd39]
    Vogal
    since 2009-05-25
  • J.M. [P-4ad2]
    Vogal
    since 2009-05-25
  • J.G. [P-fd48]
    Vogal
    since 2009-05-25
  • K.A. [P-e283]
    Administrador
    since 2009-05-25
  • L.M. [P-32be]
    Vogal
    since 2009-05-25
  • M.N. [P-d2ab]
    Administrador
    since 2009-05-25
  • O.C. [P-617b]
    Administrador
    since 2009-05-25
  • P.A. [P-723c]
    Vogal
    since 2009-03-23
  • P.J. [P-c0c1]
    Presidente
    since 2009-05-25
  • P.G. [P-0575]
    Administrador
    since 2009-05-25
  • P.M. [P-d5e4]
    Vogal
    since 2009-05-25
  • L.M. [P-32be]
    Vogal
    2009-03-23 → 2009-05-15
  • M.I. [P-5d64]
    Vogal
    2009-03-23 → 2009-05-15
  • P.A. [P-723c]
    Vogal
    until 2009-03-23
  • P.J. [P-c0c1]
    Presidente
    2009-03-23 → 2009-05-15
  • S.P. [P-6fcf]
    Vogal
    2009-03-23 → 2009-05-15
  • J.A. [P-d83c]
    Fiscal Único
    2009-03-23 → 2009-05-15
  • K.A. [P-e283]
    Fiscal Único
    2009-03-23 → 2009-05-15
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned